New Subgenotype of HBV in Southwestern China
Intervirology 2009;52:340-346 341 through its southern part. It shares a border of 4,060 km with Burma in the west, Laos in the south and Vietnam in the southeast. The province is known to be one of the most ethnically diverse in China. Until recent times most of Yunnan was not easily reachable as it has been isolated from the outside world by precipitous mountains. To our knowledge, few data on HBV genotype distribution in these areas are available.
One Dai village and 2 isolated Hani villages, located in the mountains of Jihong, the capital of Xishuangbanna Dai Autonomous Prefecture of Yunnan province, were involved in this survey by the Institute of Basic Medicine, the First People's Hospital of Yunnan Province. All subjects included were indigenous inhabitants of Jinhong. Informed consent was obtained and 411 serum samples were collected. Forty-seven samples were positive for HBsAg. HBV DNA was extracted from these 47 serum samples with phenol-chloroform, precipitated with ethanol, and resuspended in Rnase-free water and stored at -80 ° until use. Full genomes of HBV DNA were amplified from 5 patients. The 5 patients were a 37-year-old female (M84), a 14-year-old male (M85), a 16-year-old female (M118), a 27-year-old male (L15) and a 16-year-old female (G67). The first 4 were native Hanis and the last one was a native Dai. All patients were negative for antibody against hepatitis C virus and human immunodeficiency virus and were not intravenous drug abusers. They were all positive for HBsAg, HBeAg and HBcAb with high levels of HBV viral loads (2.5 ! 10 8 , 1.1 ! 10 8 , 5.2 ! 10 8 , 2.3 ! 10 8 and 1.4 ! 10 8 copies/ml, respectively), and negative for anti-HBe.
The complete HBV genome was amplified by PCR with 2 primers as previously reported [16] . The PCR reaction was performed using the following cycles: 94 ° predenatured for 5 min, 30 cycles of 94 ° for 1 min, 56 ° for 1 min, 72 ° for 2 min and 72 ° for 10 min as a final extension step. Then full-length amplicons were purified using a gel extraction kit (HuaShun Bio-Engineering Co. Ltd.). The amplicons were linked with vector pMD 18-T vector (TaKaRa Bio-Tech. Co. Ltd.) by using the standard cloning techniques. White colonies were picked; correct recombinants were confirmed by PCR and the double-restriction endonuclease digesting (EcoRI and Hind III). DNA sequencing analysis of the correct recombinants was performed with BigDye Terminator v3.1 and 3130 Genetic Analyzer (Applied Biosystems). For each patient, 3-10 recombinants were stochastically selected to be sequenced.
The whole genome sequences were assembled from sequencing data and were registered with GenBank under the accession numbers M84 (EU330988-91), M85 (EU330992-1001), M118 (EU305546-48), L15 (EU305543-45) and G67 (EU305540-42, EU330986). For each patient, a consensus sequence was created by using the BioEdit software, version 7.0.5.2 [17] , named as consensus M84, M85, M118, L15 and G67, respectively. Alignment was performed with Clustal X software, version 1.83 [18] . Phylogenetic tree analysis was carried out with MEGA software version 3.1 [19] , using the neighbor-joining method, with 1,000 bootstrapped data sets. Genetic distance calculation and pairwise distance comparisons were performed with the Kimura 2-parameter model integrated into the MEGA software.
To identify the genotypes and subgenotypes, the consensus sequences of each patient were compared with 9 reported HBV genotypes (A-I) by using the full-length nucleotide sequences. Representative isolates of genotypes/subgenotypes A-I were retrieved from DDBJ/GenBank. The accession numbers and countries of origin are: AY128092 (Ae, Canada); M57663 (Aa, Philippines); D23679, D00329, AB073858 (B1, Japan); AF282917, AB073840 (B2, China); D00331, AB033554, AB033555, M54923 (B3, Indonesia); AB219430 (B3, Philippines); AB073835, AB031266 (B4, Vietnam); AB219426-29, AB241116-17 (B5, Philippines); AY217376 (C1, China); AF068756 (C1, Thailand); AF233236, Y18857 (C2, China); X04615 (C2, Japan); X75655-56 (C3, Polynesia); AB048704-5 (C4, Australia); AB241110, AB241112-13 (C5, Philippines); AB119256 (D, Japan); AY945307 (D, India); AB205192 (E, Ghana); AP007262 (E, Japan); AY090455 (F, Nicaragua), AB036915 (F, Indonesia); AB056514 (G, USA); AP007264 (G, Japan); FJ023670, FJ023675, FJ23659 (I, Laos); and AB232908 (I, Vietnam).
The results of intergroup divergences of entire genome sequences revealed that these 5 consensus sequences were genotypes B (M84, M85, M118 and L15; 4.16-4.31% with HBV/B) and C (G67; 5.45% with HBV/C). Among the present 5 consensus sequences, 1 isolate belonged to subgenotype C1 (G67), 2 isolates belonged to subgenotype B2 (M118 and L15), and the other 2 (M84 and M85) were very similar to the subgenotype B3. We proposed that these 2 consensus isolates belong to a new HBV/B subgenotype, which we designated as B6.
Further analyses showed that the intragroup divergence of the entire genome sequences of B6 was 0-0.9%. The intergroup nucleotide divergences over the complete genome sequences between B6 and the other subgenotypes were [mean 8 SD (range)] 6.48 8 0.39% with Japan (B1), 5.01 8 0.38% with China (B2), 2.99 8 0.28% In addition, comparing precore and core genes revealed that, like in B2-B5, B6 had recombined with HBV/C in the precore and core genes (3.35 8 0.53% vs. 3.82 8 0.61%, respectively) but differed at least 5% from other genotypes (online supplementary table 1, www.karger.com/doi/10.1159/000252912. Through the construction of a phylogenetic tree by using the precore/ core gene and X gene, respectively, it was revealed that there is a new clad separating from the major trunk of genotype B with a 99% bootstrap value ( fig. 1 and 2 ). Phylogenetic tree of the X gene constructed by the neighbor-joining method using the present 5 consensus sequences and other genotype isolates retrieved from DDBJ/GenBank. Bootstrap values are indicated for each group. The length of the horizontal bar indicates the number of nucleotide substitutions per site. The 5 consensus sequences presented in this study are shown in bold. Each consensus sequence was created using all the clones from each patient.
